Pignatelli Francesco, Niro Alfredo, Viggiano Pasquale, Boscia Giacomo, Addabbo Giuseppe, Boscia Francesco, Iaculli Cristiana, Giancipoli Ermete
Eye Clinic, Hospital "SS. Annunziata", ASL Taranto, 74100 Taranto, Italy.
Department of Translational Biomedicine Neuroscience, University of Bari "Aldo Moro", 70125 Bari, Italy.
Diagnostics (Basel). 2024 Nov 21;14(23):2610. doi: 10.3390/diagnostics14232610.
Despite the abundant literature, internal limiting membrane (ILM) peeling remains a controversial topic, especially in diabetic eyes. We compared the safety and effectiveness of intraoperative optical coherence tomography (iOCT)-assisted selective epiretinal membrane (ERM) peeling with dye-assisted ERM and ILM peeling, for the treatment of tractional diabetic macular edema (tDME).
In this single-center retrospective study, we evaluated consecutive patients with tDME who underwent iOCT-assisted selective ERM peeling (Group A) or "dual blue" dye-assisted ERM and ILM peeling (Group B). Best corrected visual acuity (BCVA) and central macular thickness (CMT) were compared over a 12-month follow-up. A linear mixed model analysis was performed.
At baseline, the two groups were comparable in terms of their demographic and clinical outcomes. No significant difference between BCVA and CMT was observed among the groups. Both groups showed significant improvement in outcomes at the last follow-up ( < 0.001), although only iOCT-assisted ERM peeling ensured significant visual gain and macular thinning ( < 0.001) one month after surgery. A significant effect of time on both outcomes ( < 0.001) and of time-treatment interaction on visual change ( = 0.02) were observed. In eight patients, macular edema recurred (Group A: two patients; Group B: six patients) and was managed with an intravitreal dexamethasone implant. In Group A, one patient developed a recurrence of ERM without the need for reoperation.
iOCT-assisted ERM removal may be as effective as dye-assisted ERM and ILM peeling to treat tDME. Additionally, it ensures a quicker recovery of visual function and macular thickness. The observed ERM recurrence within the 1-year follow-up was mild and did not necessitate additional surgery.
尽管有大量文献报道,但内界膜(ILM)剥除仍是一个有争议的话题,尤其是在糖尿病性眼病中。我们比较了术中光学相干断层扫描(iOCT)辅助的选择性视网膜前膜(ERM)剥除与染料辅助的ERM及ILM剥除治疗牵拉性糖尿病性黄斑水肿(tDME)的安全性和有效性。
在这项单中心回顾性研究中,我们评估了连续接受iOCT辅助选择性ERM剥除(A组)或“双蓝”染料辅助ERM及ILM剥除(B组)的tDME患者。在12个月的随访期内比较最佳矫正视力(BCVA)和中心黄斑厚度(CMT)。进行了线性混合模型分析。
基线时,两组在人口统计学和临床结局方面具有可比性。组间BCVA和CMT未观察到显著差异。两组在末次随访时结局均有显著改善(P<0.001),尽管仅iOCT辅助的ERM剥除在术后1个月确保了显著的视力提高和黄斑变薄(P<0.001)。观察到时间对两种结局均有显著影响(P<0.001),时间-治疗交互作用对视力变化有显著影响(P = 0.02)。8例患者黄斑水肿复发(A组:2例;B组:6例),采用玻璃体内地塞米松植入治疗。A组有1例患者ERM复发,无需再次手术。
iOCT辅助的ERM去除治疗tDME可能与染料辅助的ERM及ILM剥除同样有效。此外,它能确保视觉功能和黄斑厚度更快恢复。在1年随访期内观察到的ERM复发较轻,无需额外手术。